This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
Northern Oil and Gas, Inc. (NOG - Free Report) recently agreed to buy some significant properties located in Williston Basin, ND from Pivotal Petroleum Partners, which focuses on non-operating stakes in various prolific basins
DK NOG IQV EOG
The company will follow a strong Q1-2018 performance by reporting earnings growth and free cash flows for Q2-2018, driven largely by improvement in oil prices and production growth.
Baker Hughes (BHGE - Free Report) , a GE company, recently agreed to divest its Natural Gas Solutions (“NGS”) business for a total of $375 million, through two separate deals. The buyers of the assets are First Reserve Corporation, a private-equity firm and Pietro Fiorentini S.p.A., which provides natural gas regulating and metering components.
WFC WFCNP WFC.WS GEC GE UNP WFC.PRL WFC.PRJ EOG WFC.PRT BHI WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN GNE WFC.PRY WFC.PRX WFC.PRW WFC.PRV
President Trump’s administration passed a tax plan in December that was enacted in January and revolved mainly around corporate tax cuts and personal tax rate adjustment. The plan cuts the corporate rate from 35% to 21%.
SLIM IBUY XOM PSCH FDN EOG
The SPDR Energy Select Sector, formed in late-1998, has more than $19Bn of assets under management, which makes it one of the most well established ETFs in the industry.
XLE VDE FENY KMI.WS XOM NOV SU VNGE EOG SQTI KMI.PRA KMI SLB SND KMR CVB KMRFZ SU
Schlumberger Limited (SLB - Free Report) is scheduled to report second-quarter 2018 earnings on Jul 20, before the opening bell. In the last reported quarter, the company delivered a positive earnings surprise of 0.00%, courtesy of a surge in North American directional land drilling operations and awards for Integrated Production Services (IPS) contracts. Moreover, Schlumberger delivered an average positive earnings surprise of 6.
COP SLB VEEV SCL SLB OXY SGH EOG
One stock that might be an intriguing choice for investors right now is EOG Resources, Inc. (EOG - Free Report) . This is because this security in the Oil and Gas - Exploration and Production - United States space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
GTT KRYS EOG
The markets have been witnessing a bull run in the first two weeks of July, signaling a recovery for Wall Street. Global trade war concerns and fear of growing inflation in the U.S. economy had been plaguing the U.S. stock markets for the first half of 2018. In fact, stock market momentum remained largely unhindered despite recent volatility. Gradual easing of trade conflicts, steady economic activities and business-friendly policies adopted by the government will pave the way for further upside.
COP ATU POOL GTT KMX FRSH CAXPF EOG
Kinder Morgan Inc (KMI - Free Report) is expected to post second-quarter 2018 results on Jul 18. In the last reported quarter, the company delivered positive earnings surprise of 4.8%. Moreover, the company has pulled off an average positive earnings surprise of 7.1% in the last four quarters. Let’s see how things are shaping up prior to the announcement. Which Way are Estimates Treading? Let’s look at the estimate revisions to get a clear picture of what analysts are thinking about the company before earnings release.
COP POOL KMI.PRA KMI GTT KMI.WS OXY KMR KMRFZ CVB EOG
A large $2.3 billion acquisition like Comanche often takes a few years to optimize results. The previous large acquisition, Catarina, took a few years.
SN APC CKRGZ CHKVP BGFLX SCAZP LNR CHKDH CHKVZ CHKDG EOG CHKWZ CHKDJ CHKDP CHK.WI CHK CHK.PRD SNZYP AEUA
Tallgrass Energy, LP (TGE - Free Report) along with Silver Creek Midstream, LLC recently launched a binding open season to obtain supplemental shipping agreements for their Niobrara (API 34 - 42) crude oil transportation service that uses the Iron Horse Pipeline.
It’s earnings time again and investors are back to watching the quarterly releases closely. This time as well, we expect the Energy sector to contribute the maximum to earnings growth for the S&P 500.
COP APC CTLR MRO CLR AEUA EOG
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to EOG / EOG Resources, Inc. on message board site Silicon Investor.
as of ET